Conjunctivitis: Clinical Trials

5 trials for Conjunctivitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5
Phase 11Unknown 1
Phase 31Unknown 1

Follow Conjunctivitis: new trials by email Literature Review of Conjunctivitis trials Research Report on Conjunctivitis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of TL-925 for the Treatment of Allergic Conjunctivitis
TL-925, Placebo - Allergic Conjunctivitis
Phase 2UnknownTelios Pharma, Inc.702023-11-012023-12-01
Treatment of Dry Eye Disease Using Pro-ocularâ„¢ - A Proof of Concept, Safety, and Efficacy Study
Pro-ocularâ„¢ Topical Gel, Placebo Topical Gel - Dry Eye Syndrome, Keratoconjunctivitis Sicca
Phase 2UnknownPharmaDax Inc.802021-05-202021-05-14
The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
Allergen(Tree, Grass, Weeds) - Allergic Rhinitis, Asthma
Phase 1 / Phase 2UnknownUniversity Hospitals Cleveland Medical Center2452013-04-012013-06-17
Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
Mixture of probiotic bacteria and prebiotic oligosaccharide - Atopic Dermatitis, Food Hypersensitivity
Phase 2 / Phase 3UnknownUniversity of Helsinki1999-10-012006-10-18
Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
Tacrolimus 0.03% ointment (Protopic) - Allergic Conjunctivitis
Phase 2UnknownAssaf-Harofeh Medical Center2007-03-05

Narrower conditions

Conjunctivitis, Allergic (4)  ·  Asthma (2)  ·  Dermatitis, Atopic (1)  ·  Dry Eye Syndromes (1)  ·  Food Hypersensitivity (1)  ·  Keratoconjunctivitis Sicca (1)  ·  Rhinitis, Allergic (1)  ·  Rhinitis, Allergic, Seasonal (1)

Broader conditions

Conjunctival Diseases (5)  ·  Eye Diseases (5)  ·  Hypersensitivity (4)  ·  Hypersensitivity, Immediate (4)  ·  Immune System Diseases (4)  ·  Bronchial Diseases (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Nose Diseases (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Respiratory Hypersensitivity (2)  ·  Respiratory Tract Diseases (2)  ·  Rhinitis (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Ointments (1)  ·  Tacrolimus (1)  ·  nabiximols (1)

Sponsors

Assaf-Harofeh Medical Center (1)  ·  PharmaDax Inc. (1)  ·  Telios Pharma, Inc. (1)  ·  University Hospitals Cleveland Medical Center (1)  ·  University of Helsinki (1)

Countries

United States (2)  ·  Finland (1)  ·  Israel (1)  ·  Taiwan (1)

Top investigators

David Zadok, MD (1)  ·  Devi K Jhaveri, D.O. (1)  ·  Erkki Savilahti, Professor (1)  ·  Haig Tcheurekdjian, M.D. (1)  ·  Peichun Kuo (1)

Results publications

PMID 18595980, PMID 21771118, PMID 22093109, PMID 30326954, PMID 30472801, PMID 34857814, PMID 37438187, PMID 38687061